Author

Nianzhuang Qiu

Shandong First Medical UniversityORCID 0009-0007-6786-1269Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1 Organism:mouse· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

Chenliang QianiD· 1 shared Hao WangiD· 1 shared Hongwei JiniD· 1 shared Jie XiaiD· 1 shared Mei LiiD· 1 shared Mingli Yao· 1 shared Song WuiD· 1 shared Tianyang Guo· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

Chenliang QianORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Pharmacology & ToxicologyInternational Journal of Biological MacromoleculesPeer-reviewedMay 2, 2024

Discovery of a Novel Chemotype as DYRK1A Inhibitors against Alzheimer's disease: Computational Modeling and Biological Evaluation

Nianzhuang Qiu, Chenliang Qian, Tingting Guo…·Jie Xia

This paper identifies a novel DYRK1A inhibitor, compound Q17, through computational screening and validates its efficacy in reducing AD-related pathology in vitro and in vivo.

8 citations

mouseproteomics

𝕏 PostBluesky